With improved early gastric cancer detection rates, endoscopic treatment has gained popularity due to advances in existing equipment and the experience of endoscopists. The purpose of this review is to summarize the endoscopic diagnosis and treatment commonly used in early gastric cancer (early gastric cancer).

Abbreviation H. pylori-associated gastric cancer (HpPGC) Stomach cancer not caused by H. pylori infection ( Stomach cancer not caused by H. pylori infection ) Persistent Helicobacter pylori ( H. pylori ) infection causing chronic inflammation, atrophy of the gastric mucosa and a high risk of developing gastric cancer. In recent years, awareness of H.pylori eradication treatment has increased in Vietnam. As H. pylori infection decreases, the incidence of gastric cancer arising from gastric mucosa that is not infected with H. pylori increases. The occurrence of gastric cancer arising in patients without H. pylori infection, although rarely reported, is a concern that needs to be addressed and should elucidate the clinical features of this disease. it.

Many new endoscopic techniques have been shown to increase the likelihood of early gastric cancer diagnosis. With improved early gastric cancer detection rates, endoscopic treatment has gained popularity due to advances in existing equipment and the experience of endoscopists. The purpose of this review is to summarize the endoscopic diagnosis and treatment commonly used in early gastric cancer (early gastric cancer).

Endoscopy is the mainstay method for early gastric cancer screening because of its high detection rate, however, diagnostic accuracy is highly dependent on the availability of endoscopic instruments. Many new endoscopic techniques have been shown to increase the likelihood of early gastric cancer diagnosis.

Stomach cancer is a common disease, with the second leading cause of death in the world. The early diagnosis and treatment of stomach cancer will help improve the mortality rate in patients. Currently, the pepsinogen test is the noninvasive screening solution used for risk assessment and early detection of gastric cancer in at-risk patients.